|
1
|
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.
|
J Infect Dis
|
2006
|
2.82
|
|
2
|
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.66
|
|
3
|
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs).
|
PLoS One
|
2008
|
1.63
|
|
4
|
Global functional analyses of cellular responses to pore-forming toxins.
|
PLoS Pathog
|
2011
|
1.52
|
|
5
|
Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events.
|
FASEB J
|
2001
|
1.28
|
|
6
|
Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
|
Circulation
|
2004
|
1.26
|
|
7
|
Pore-forming Staphylococcus aureus alpha-toxin triggers epidermal growth factor receptor-dependent proliferation.
|
Cell Microbiol
|
2006
|
1.23
|
|
8
|
Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium.
|
Biochem Biophys Res Commun
|
2009
|
1.15
|
|
9
|
Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis.
|
EMBO J
|
2012
|
1.01
|
|
10
|
Pro-autophagic signal induction by bacterial pore-forming toxins.
|
Med Microbiol Immunol
|
2010
|
0.98
|
|
11
|
Beyond cholesterol: the enigma of atherosclerosis revisited.
|
Thromb Haemost
|
2004
|
0.94
|
|
12
|
Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.93
|
|
13
|
A subunit of eukaryotic translation initiation factor 2α-phosphatase (CreP/PPP1R15B) regulates membrane traffic.
|
J Biol Chem
|
2012
|
0.90
|
|
14
|
Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
|
Thromb Haemost
|
2008
|
0.90
|
|
15
|
Modulation of translation and induction of autophagy by bacterial exoproducts.
|
Med Microbiol Immunol
|
2012
|
0.90
|
|
16
|
Interferons increase cell resistance to Staphylococcal alpha-toxin.
|
Infect Immun
|
2007
|
0.84
|
|
17
|
Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity.
|
J Biol Chem
|
2011
|
0.84
|
|
18
|
Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis.
|
Arterioscler Thromb Vasc Biol
|
2003
|
0.81
|
|
19
|
Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteins.
|
Cell Microbiol
|
2011
|
0.81
|
|
20
|
Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: role of free fatty acids.
|
Circulation
|
2002
|
0.79
|
|
21
|
Hypersusceptibility of neutrophil granulocytes towards lethal action of free fatty acids contained in enzyme-modified atherogenic low density lipoprotein.
|
Atherosclerosis
|
2009
|
0.75
|
|
22
|
Enzymatically hydrolyzed low-density lipoprotein modulates inflammatory responses in endothelial cells.
|
Thromb Haemost
|
2008
|
0.75
|